Insmed Inc
INSM137.030USD
+1.440+1.06%
Close 09/26, 16:00（ET）Quotes delayed by 15 min
28.93BMarket Cap
LossP/E TTM
More Details of Company
Company Info
Ticker SymbolINSM
Company nameInsmed Inc
IPO dateFeb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
Number of employees1271
Security typeOrdinary Share
Fiscal year-endFeb 15
Address700 Us Highway 202/206
CityBRIDGEWATER
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code08807
Phone19089779900
Websitehttps://insmed.com/
Ticker SymbolINSM
IPO dateFeb 15, 1991
CEOMr. William H. (Will) Lewis, J.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
Dr. Martina Flammer, M.D.
Dr. Martina Flammer, M.D.
Chief Medical Officer
Chief Medical Officer
4.27K
-66.30%
Ms. Sara M. Bonstein
Ms. Sara M. Bonstein
Chief Financial Officer
Chief Financial Officer
239.00
-98.89%
Mr. Leo Lee
Mr. Leo Lee
Independent Director
Independent Director
--
--
Mr. Bryan Dunn
Mr. Bryan Dunn
Vice President, Investor Relations
Vice President, Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. William H. (Will) Lewis, J.D.
Mr. William H. (Will) Lewis, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
402.00K
-2.59%
Dr. Melvin A. Sharoky, M.D.
Dr. Melvin A. Sharoky, M.D.
Independent Director
Independent Director
308.40K
-3.70%
Mr. David R. Brennan
Mr. David R. Brennan
Lead Independent Director
Lead Independent Director
113.77K
+4.65%
Dr. Clarissa Desjardins, Ph.D.
Dr. Clarissa Desjardins, Ph.D.
Independent Director
Independent Director
53.84K
+10.37%
Ms. Carol Anne Schafer
Ms. Carol Anne Schafer
Independent Director
Independent Director
50.16K
+11.22%
Mr. Roger Adsett
Mr. Roger Adsett
Chief Operating Officer
Chief Operating Officer
25.55K
-49.45%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
No Data
By RegionUSD
Name
Revenue
Proportion
US
64.28M
69.24%
Japan
22.08M
23.79%
Europe and rest of worldld
6.46M
6.96%
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, Sep 5
Updated: Fri, Sep 5
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
Other
66.88%
Shareholders
Shareholders
Proportion
Darwin Global Management Ltd
9.15%
The Vanguard Group, Inc.
8.33%
JP Morgan Asset Management
6.14%
T. Rowe Price Associates, Inc.
5.24%
BlackRock Institutional Trust Company, N.A.
4.26%
Other
66.88%
Shareholder Types
Shareholders
Proportion
Investment Advisor
44.44%
Hedge Fund
26.91%
Investment Advisor/Hedge Fund
22.20%
Research Firm
2.99%
Family Office
1.09%
Bank and Trust
0.92%
Sovereign Wealth Fund
0.92%
Pension Fund
0.85%
Individual Investor
0.67%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
807
207.14M
108.81%
-3.07M
2025Q1
804
211.64M
111.66%
-239.74K
2024Q4
767
205.04M
113.32%
-2.57M
2024Q3
712
200.94M
112.58%
+1.71M
2024Q2
657
186.57M
112.00%
+21.58M
2024Q1
564
156.59M
105.42%
-6.86M
2023Q4
544
155.47M
105.16%
-6.81M
2023Q3
515
153.95M
107.69%
-8.46M
2023Q2
506
152.37M
106.87%
-10.75M
2023Q1
511
151.28M
110.90%
-8.90M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Darwin Global Management Ltd
15.40M
8.12%
+2.44M
+18.81%
Mar 31, 2025
The Vanguard Group, Inc.
18.23M
9.61%
+47.77K
+0.26%
Mar 31, 2025
JP Morgan Asset Management
5.41M
2.85%
+2.51M
+86.84%
Mar 31, 2025
T. Rowe Price Associates, Inc.
12.76M
6.73%
+212.23K
+1.69%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
13.00M
6.85%
-170.21K
-1.29%
Mar 31, 2025
Baker Bros. Advisors LP
5.38M
2.84%
+373.76K
+7.47%
Mar 31, 2025
Capital International Investors
7.20M
3.79%
+81.49K
+1.14%
Mar 31, 2025
Fidelity Management & Research Company LLC
3.34M
1.76%
-1.33M
-28.48%
Mar 31, 2025
State Street Global Advisors (US)
5.75M
3.03%
-358.86K
-5.88%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Invesco Dorsey Wright Healthcare Momentum ETF
5.42%
BNY Mellon Innovators ETF
3.76%
VanEck Biotech ETF
3.65%
Franklin Genomic Advancements ETF
3.46%
SPDR S&P Biotech ETF
2.5%
ProShares Ultra Nasdaq Biotechnology
2.04%
Invesco Nasdaq Biotechnology ETF
2.04%
Virtus LifeSci Biotech Products ETF
2%
iShares Biotechnology ETF
1.86%
Direxion Daily S&P Biotech Bull 3X Shares
1.43%
View more
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion5.42%
BNY Mellon Innovators ETF
Proportion3.76%
VanEck Biotech ETF
Proportion3.65%
Franklin Genomic Advancements ETF
Proportion3.46%
SPDR S&P Biotech ETF
Proportion2.5%
ProShares Ultra Nasdaq Biotechnology
Proportion2.04%
Invesco Nasdaq Biotechnology ETF
Proportion2.04%
Virtus LifeSci Biotech Products ETF
Proportion2%
iShares Biotechnology ETF
Proportion1.86%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion1.43%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
